Second Genome

Gilead to lean on Second Genome's microbiome work in $38M research pact
Gilead to lean on Second Genome's microbiome work in $38M research pact
BioPharma Dive
Gilead Sciences
Second Genome
microbiome
R&D
Flag link:
Microbiome Report for Week Ending 4/13/19
Microbiome Report for Week Ending 4/13/19
CP Wire
MaaT Pharma
MaaT013
aGvHD
Second Genome
SkinBio Therapeutics
Azitram AZT-02
Netherton Syndrome
Flag link:
Microbiome Report for Week Ending 4/13/19
MaaT Pharma
MaaT013
aGvHD
Second Genome
SkinBio Therapeutics
Azitram AZT-02
Netherton Syndrome
Flag link:
Microbiome Report for Week Ending 1/26/19
Microbiome Report for Week Ending 1/26/19
CP Wire
microbiome
Second Genome
Vedanta Biosciences
NASH
Immune Biotech
Flag link:
Evotec Receives Milestone Payment for Beginning Phase II NASH Clinical Trial
Evotec Receives Milestone Payment for Beginning Phase II NASH Clinical Trial
CP Wire
Evotec
Second Genome
NASH
SGM-1019
Flag link:
Evotec Receives Milestone Payment for Beginning Phase II NASH Clinical Trial
Evotec
Second Genome
NASH
SGM-1019
Flag link:
Microbiome Report for Week Ending 9/29/18
Microbiome Report for Week Ending 9/29/18
CP Wire
microbiome
Second Genome
4D Pharma
Thetanix
Flag link:
Microbiome Report for Week Ending 9/29/18
microbiome
Second Genome
4D Pharma
Thetanix
Flag link:
The Great Drive to Develop Treatments for NASH continues with Second Genome Presenting Data Supporting Development of Its P2X7 Inhibitor, SGM-1019
The Great Drive to Develop Treatments for NASH continues with Second Genome Presenting Data Supporting Development of Its P2X7 Inhibitor, SGM-1019
CP Wire
Second Genome
SGM-1019
NASH
Flag link:
The Great Drive to Develop Treatments for NASH continues with Second Genome Presenting Data Supporting Development of Its P2X7 Inhibitor, SGM-1019
Second Genome
NASH
Flag link:
Pfizer, Roche Embrace The Microbiome, Leading $43M Bet On Second Genome
Pfizer, Roche Embrace The Microbiome, Leading $43M Bet On Second Genome
Forbes
Pfizer
Roche
microbiome
Second Genome
Flag link:
Pfizer jumps on the microbiome bandwagon with expansive Second Genome deal
Pfizer jumps on the microbiome bandwagon with expansive Second Genome deal
Fierce Biotech
Second Genome
Pfizer
obesity
microbiome
Flag link:
Johnson & Johnson's Gut Feeling About the Future of Medicine
Johnson & Johnson's Gut Feeling About the Future of Medicine
Motley Fool
JNJ
microbiome
Second Genome
Flag link:
Second Genome announces agreement with Janssen
Second Genome announces agreement with Janssen
Yahoo/Fly on the Wall
Janssen
Second Genome
Flag link: